Pathologic Audit of 164 Consecutive Cases of Vulvar Intraepithelial Neoplasia
- 1 April 2006
- journal article
- pathology of-the-lower-genital-tract
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 25 (2) , 176-181
- https://doi.org/10.1097/01.pgp.0000189238.19027.df
Abstract
Summary: There are 2 types of vulvar intraepithelial neoplasia (VIN): warty-basaloid and differentiated. Differentiated VIN is uncommon and seldom diagnosed prior to carcinoma and, traditionally, is not graded. There are currently 3 grading systems for warty-basaloid VIN: the World Health Organization (WHO) 3 grade system of VIN 1-3, a 2 grade system of low and high grade vulvar intraepithelial lesions, and the revised International Society for the Study of Vulvovaginal Disease (ISSVD) classification which has no grading of VIN. According to the ISSVD, VIN 1 should be abolished and VIN 2 and 3 combined into a single category, simply termed warty-basaloid VIN. To determine the best system for grading warty-basaloid VIN and learn more about differentiated VIN, we reviewed the pathology of 164 consecutive women with VIN. Of these, 134 (82.3%) had warty-basaloid VIN, 29 (18.2%) had differentiated VIN, and 1 had both. Of warty-basaloid VIN cases, 4 had VIN 1, 13 VIN 2, and 118 VIN 3 when graded according to the WHO. All VIN 1 occurred in condylomata acuminata. VIN 2 and 3 were distinguished only by degree of abnormality. Differentiated VIN was diagnosed before SCC in only 7 cases (26.7%). Because the only VIN 1 cases seen were in condylomata acuminata and because VIN 2 and 3 were difficult to distinguish and there appears little clinical reason to do so, our study supports the ISSVD proposal that VIN 1 be abolished and VIN 2 and 3 be combined. There needs to be more clinical awareness of vulvar conditions, so that differentiated VIN is biopsied before cancer has supervened.Keywords
This publication has 17 references indexed in Scilit:
- TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulvaBritish Journal of Cancer, 2003
- Symposium Part 1: Should the Bethesda System Terminology be Used in Diagnostic Surgical Pathology?: PointInternational Journal of Gynecological Pathology, 2003
- Overexpression of Wild-type p53 in Lichen Sclerosus adjacent to Human Papillomavirus-negative Vulvar CancerJournal of Investigative Dermatology, 2002
- Allelic Imbalance in Lichen Sclerosus, Hyperplasia, and Intraepithelial Neoplasia of the VulvaGynecologic Oncology, 2000
- Human papillomavirus, lichen sclerosis and vulvar squamous cell carcinomaInternational Journal of Gynecologic Cancer, 1998
- p53 Protein Overexpression, a Frequent Observation in Squamous Cell Carcinoma of the Vulva and in Various Synchronous Vulvar Epithelia, Has No Value as a Prognostic ParameterInternational Journal of Gynecological Pathology, 1997
- p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: Evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomasHuman Pathology, 1996
- Basaloid and Warty Carcinomas of the VulvaThe American Journal of Surgical Pathology, 1993
- A histological assessment of normal vulval skinClinical and Experimental Dermatology, 1983
- Premalignant Conditions of the Vulva, with Particular Reference to Chronic Epithelial DystrophiesBMJ, 1961